Elucid Bioimaging is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Based in the United States, Elucid Bioimaging is a startup founded in 2016. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Elucid Bioimaging is a medical technology company leveraging machine intelligence to improve the accuracy, experience, and cost-effectiveness of vascular diagnostic imaging. Its flagship product, PlaqueIQ, is the first FDA-cleared and CE-marked, histology-validated, non-invasive image analysis software for evaluating coronary CT angiograms to provide multi-dimensional visualization, structural measurements, and plaque composition to inform risk of heart attack or stroke and personalized treatmen
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.